Epidemiology of cervical cancer with special focus on India.

Aswathy Sreedevi, Reshma Javed, Avani Dinesh
Author Information
  1. Aswathy Sreedevi: Community Medicine, AIMS, Kochi, Amrita Vishwa Vidyapeetham, Kerala, India.
  2. Reshma Javed: Community Medicine, AIMS, Kochi, Amrita Vishwa Vidyapeetham, Kerala, India.
  3. Avani Dinesh: Community Medicine, AIMS, Kochi, Amrita Vishwa Vidyapeetham, Kerala, India.

Abstract

Cervical cancer is on the declining trend in India according to the population-based registries; yet it continues to be a major public health problem for women in India. Multifactorial causation, potential for prevention, and the sheer threat it poses make cervical cancer an important disease for in-depth studies, as has been attempted by this paper. This paper attempts to review the available knowledge regarding the epidemiology and pattern of cervical cancer; types of HPV (human papilloma virus) prevalent among cervical cancer patients and among women in general, high-risk groups such as commercial sex workers, and HIV (human immunodeficiency virus)-positive women; and the role of the national program on cancer in control efforts. The peak age of incidence of cervical cancer is 55-59 years, and a considerable proportion of women report in the late stages of disease. Specific types of oncogenic HPV-16, 18 have been identified in patients with cervical cancer. Other epidemiological risk factors are early age at marriage, multiple sexual partners, multiple pregnancies, poor genital hygiene, malnutrition, use of oral contraceptives, and lack of awareness. A multipronged approach is necessary which can target areas of high prevalence identified by registries with a combination of behavior change communication exercises and routine early screening with VIA. Sensitizing the people of the area, including menfolk, is necessary to increase uptake levels. Vaccination against types 16 and 18 can also be undertaken after taking into confidence all stakeholders, including the parents of adolescent girls. Preventing and treating cervical cancer and reducing the burden are possible by targeting resources to the areas with high prevalence.

Keywords

References

  1. Int J Cancer. 2005 Sep 20;116(5):830-1 [PMID: 15849748]
  2. Am J Epidemiol. 1976 May;103(5):512-7 [PMID: 1274953]
  3. Lancet. 1980 Aug 23;2(8191):417 [PMID: 6105530]
  4. Int J STD AIDS. 1998 Feb;9(2):98-103 [PMID: 9506375]
  5. J Biosci. 2012 Mar;37(1):63-72 [PMID: 22357204]
  6. N Engl J Med. 2009 Apr 2;360(14):1385-94 [PMID: 19339719]
  7. Int J Cancer. 2000 Jul 15;87(2):221-7 [PMID: 10861478]
  8. Asian Pac J Cancer Prev. 2012;13(12):6333-6 [PMID: 23464454]
  9. Image J Nurs Sch. 1997 Spring;29(1):27-32 [PMID: 9127537]
  10. Indian J Palliat Care. 2013 Sep;19(3):158-65 [PMID: 24347906]
  11. Cytopathology. 2009 Aug;20(4):249-55 [PMID: 19018810]
  12. Indian J Med Res. 2009 Sep;130(3):234-40 [PMID: 19901432]
  13. BMC Infect Dis. 2011 Mar 22;11:72 [PMID: 21418663]
  14. Int J Cancer. 2003 Jul 10;105(5):687-91 [PMID: 12740919]
  15. Int J Cancer. 2004 Jan 20;108(3):329-33 [PMID: 14648697]
  16. Discov Med. 2012 Aug;14(75):125-31 [PMID: 22935209]
  17. N Engl J Med. 2005 Nov 17;353(20):2158-68 [PMID: 16291985]
  18. Asian Pac J Cancer Prev. 2011;12(3):645-8 [PMID: 21627358]
  19. N Engl J Med. 1998 Feb 12;338(7):423-8 [PMID: 9459645]
  20. J Adolesc Health. 2005 Dec;37(6 Suppl):S3-9 [PMID: 16310138]
  21. Bull World Health Organ. 2001;79(10):954-62 [PMID: 11693978]
  22. Cancer Epidemiol. 2010 Apr;34(2):157-61 [PMID: 20153993]
  23. Indian J Cancer. 2006 Jul-Sep;43(3):110-6 [PMID: 17065768]
  24. PLoS Med. 2008 Jun 17;5(6):e132 [PMID: 18563963]
  25. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):242s-247s [PMID: 12646519]
  26. Asian Pac J Cancer Prev. 2012;13(6):2991-5 [PMID: 22938495]
  27. Ann Oncol. 2011 Dec;22(12):2675-2686 [PMID: 21471563]
  28. Vaccine. 2009 Jan 29;27(5):636-9 [PMID: 19056450]
  29. PLoS One. 2010 Jan 08;5(1):e8634 [PMID: 20072610]
  30. Int J Gynecol Pathol. 2012 Mar;31(2):178-183 [PMID: 22317877]
  31. Vaccine. 2008 Jun 2;26(23):2811-7 [PMID: 18450340]
  32. Lancet. 2007 Aug 4;370(9585):398-406 [PMID: 17679017]
  33. Int J Infect Dis. 2007 Nov;11 Suppl 2:S3-9 [PMID: 18162244]
  34. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):107-17 [PMID: 17291240]
  35. Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9 [PMID: 15950365]
  36. Indian J Med Res. 2009 Sep;130(3):219-21 [PMID: 19901430]
  37. Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):27-34 [PMID: 19469620]
  38. Vaccine. 2006 Aug 31;24 Suppl 3:S3/71-7 [PMID: 16950020]
  39. Br J Cancer. 2005 Feb 14;92(3):601-6 [PMID: 15668709]
  40. Br J Cancer. 2011 Aug 23;105(5):723-30 [PMID: 21829198]
  41. Asian Pac J Cancer Prev. 2012;13(3):1019-24 [PMID: 22631631]
  42. BMC Infect Dis. 2005 Dec 22;5:116 [PMID: 16371167]
  43. Sex Transm Dis. 2011 Oct;38(10):902-6 [PMID: 21934560]
  44. Int J Gynaecol Obstet. 2006 Nov;94 Suppl 1:S65-S70 [PMID: 29644636]
  45. Indian J Med Res. 2012 Aug;136(2):205-10 [PMID: 22960886]
  46. J Obstet Gynaecol. 2010;30(7):725-8 [PMID: 20925620]
  47. J Infect Dis. 2005 Jan 15;191(2):182-92 [PMID: 15609227]
  48. Indian J Cancer. 2009 Apr-Jun;46(2):155-9 [PMID: 19346651]
  49. J Natl Cancer Inst. 1995 Jun 7;87(11):796-802 [PMID: 7791229]
  50. J Infect Public Health. 2008;1(2):121-8 [PMID: 20701853]
  51. Asian Pac J Cancer Prev. 2004 Jul-Sep;5(3):308-15 [PMID: 15373712]
  52. Int J Cancer. 2004 Nov 1;112(2):341-7 [PMID: 15352050]

Grants

  1. D43 TW008332/FIC NIH HHS

Word Cloud

Created with Highcharts 10.0.0cancercervicalIndiawomentypesregistriespreventiondiseasepaperepidemiologyHPVhumanvirusamongpatientsage18identifiedearlymultiplenecessarycanareashighprevalencescreeningincludingCervicaldecliningtrendaccordingpopulation-basedyetcontinuesmajorpublichealthproblemMultifactorialcausationpotentialsheerthreatposesmakeimportantin-depthstudiesattemptedattemptsreviewavailableknowledgeregardingpatternpapillomaprevalentgeneralhigh-riskgroupscommercialsexworkersHIVimmunodeficiency-positiverolenationalprogramcontroleffortspeakincidence55-59yearsconsiderableproportionreportlatestagesSpecificoncogenicHPV-16epidemiologicalriskfactorsmarriagesexualpartnerspregnanciespoorgenitalhygienemalnutritionuseoralcontraceptiveslackawarenessmultiprongedapproachtargetcombinationbehaviorchangecommunicationexercisesroutineVIASensitizingpeopleareamenfolkincreaseuptakelevelsVaccination16alsoundertakentakingconfidencestakeholdersparentsadolescentgirlsPreventingtreatingreducingburdenpossibletargetingresourcesEpidemiologyspecialfocus

Similar Articles

Cited By